Cannarma, a Delhi-based startup specializing in Ayurvedic hemp-based products, has raised $3 million to enhance marketing, global expansion, IP development, and team enhancement. This funding will also boost its distribution channels.
Funding Goals: Cannarma’s $3 million funding round aims to support marketing, global expansion, IP development, and team enhancement, driving innovation in the medicinal cannabis space.
Product Range: Founded in 2022 by Rohit Chauhan and Keshav Agarwal, Cannarma offers Ayurvedic products like medicinal cannabis, hemp seed oil, and CBD oil, produced in a GMP-certified facility.
Market Potential: The medicinal cannabis market, valued at $19.44 billion in 2024, is projected to reach $82.27 billion by 2031, growing at a CAGR of 22.9%.
Leadership and Vision: Cannarma’s advisory board includes experts like Mihir Kapoor, Dr. Deepak Pant, and Prakash Khalate. The company combines modern science with traditional Ayurveda, sourcing raw materials from Himachal Pradesh.
Conclusion: With this new funding, Cannarma is poised to expand its market presence and innovate in Ayurvedic hemp products. Stay tuned with Startup India News for more updates on Cannarma’s journey and impact. To know interesting facts about India’s Startup Ecosystem click here.
